Detalhe da pesquisa
1.
Autologous bone marrow-derived mesenchymal stromal cell therapy with early tacrolimus withdrawal: The randomized prospective, single-center, open-label TRITON study.
Am J Transplant
; 21(9): 3055-3065, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33565206
2.
Diabetic nephropathy alters circulating long noncoding RNA levels that normalize following simultaneous pancreas-kidney transplantation.
Am J Transplant
; 20(12): 3451-3461, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32353171
3.
Human leukocyte antigen selected allogeneic mesenchymal stromal cell therapy in renal transplantation: The Neptune study, a phase I single-center study.
Am J Transplant
; 20(10): 2905-2915, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32277568
4.
Circulating Long Noncoding RNA LNC-EPHA6 Associates with Acute Rejection after Kidney Transplantation.
Int J Mol Sci
; 21(16)2020 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32764470
5.
Left Atrial Structural and Functional Response in Kidney Transplant Recipients Treated With Mesenchymal Stromal Cell Therapy and Early Tacrolimus Withdrawal.
J Am Soc Echocardiogr
; 36(2): 172-179, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36347387
6.
HLA-DQ eplet mismatch load may identify kidney transplant patients eligible for tacrolimus withdrawal without donor-specific antibody formation after mesenchymal stromal cell therapy.
HLA
; 102(1): 3-12, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36841928
7.
Cardiovascular Effects of Autologous Bone Marrow-Derived Mesenchymal Stromal Cell Therapy With Early Tacrolimus Withdrawal in Renal Transplant Recipients: An Analysis of the Randomized TRITON Study.
J Am Heart Assoc
; 10(24): e023300, 2021 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34913362
8.
Single antigen testing to reduce early antibody-mediated rejection risk in female recipients of a spousal donor kidney.
Transpl Immunol
; 67: 101407, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33975014